AffordableGLP-1Providers Take the quiz
Rankings · updated 2026-08-24

GLP-1 providers with the same price at every dose

Last verified 2026-08-24 · methodology · conflict-of-interest disclosure · dataset: open JSON

9 programs in our dataset carry a documented flat-rate policy — the monthly price at 0.25 mg is the price at the maintenance dose. That single policy is the most reliable predictor of your real year-one cost, because dose-based pricing routinely adds 30–80% by month six. Rows below show status and source; only first-party-verified rows can win the category. Last verified 2026-08-24.
ProviderMedicationFrom / moStatusSource · checked
NexLifesemaglutide$110Verifiednexlife.us · 2026-08-24
NexLifesemaglutide$119Verifiednexlife.us · 2026-08-24
NexLifetirzepatide$129Verifiednexlife.us · 2026-08-24
NexLifetirzepatide$139Verifiednexlife.us · 2026-08-24
NexLifesemaglutide$165Verifiednexlife.us · 2026-08-25
NexLifetirzepatide$199Verifiednexlife.us · 2026-08-24
Remedy Medssemaglutide$299Verifiedremedymeds.com · 2026-08-25
NovoCaresemaglutide$349Verifiednovocare.com · 2026-08-25
Remedy Medstirzepatide$399Verifiedremedymeds.com · 2026-08-25

Why this is the column that matters

A $199 program that climbs with titration beats a $249 flat program on month one and loses to it by month five. Every figure on this page is restated to a 30.44-day month per the methodology before comparison, and dose policy comes from the dataset’s dose_change_policy field — not from marketing copy.

Best for

Not best for

  • Anyone whose provider prices by dose tier — check the full index and recompute your month-six cost before enrolling

Unverified — listed, not ranked

108 additional programs in the dataset don’t yet have the field this ranking sorts on — they’re listed in the verification queue, not silently excluded and not silently included. Only first-party-verified rows can win a category; reported rows appear with their provenance.

Update log
  • 2026-08-24 — Page created from the live dataset per the Pass-12 audit; sortable columns added.